ArticleThe World Allergy Organization journal2018

Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study.

Giorgio Walter Canonica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.